| Business Summary | | Cardiac
Science,
Inc.
owns
a
technology
platform
that
consists
of
proprietary
arrhythmia
detection
and
discrimination
software
and
defibrillation
hardware
and
electrode
technology,
which
are
combined
to
create
a
line
of
fully
automatic
external
cardioverter
defibrillator
(AECD)
devices.
These
AECDs
are
designed
to
be
prophylactically
attached
to
patients
at
temporary
risk
of
sudden
cardiac
arrest,
and
will
continuously
monitor
a
patient's
heart
rhythms;
instantly
and
accurately
detect
the
onset
of
any
life-threatening
arrhythmias;
and
when
appropriate
and
without
the
aid
of
hospital
staff,
automatically
deliver
potentially
life
saving
defibrillation
shocks
within
seconds
to
convert
a
patient's
heart
back
to
its
normal
rhythm.
The
Company's
Powerheart
is
the
only
FDA
cleared,
fully
automatic
non-invasive
external
cardioverter
defibrillator
device.
The
Company
is
also
currently
developing
two
additional
AECD
products:
Cardiac
Rhythm
Module
and
Personal
Wearable
Defibrillator. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cardiac
Science,
Inc.
develops
automatic
external
cardioverter
defibrillator
devices,
and
manufactures
and
distributes
cardiac
devices
and
supplies.
For
the
six
months
ended
6/30/01,
revenues
rose
45%
to
$2.2
million.
Net
loss
rose
from
$5.5
million
to
$12.4
million.
Revenues
reflect
higher
sales
of
defibrillators,
patient
monitoring
equipment
and
Powerheart
units.
Higher
loss
reflects
an
increase
in
R&D
and
S/G/A
costs
due
to
higher
salaries
and
benefits
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Paul Quadros, 53 Chairman | -- | Raymond Cohen, 40 Pres,
CEO | $236K | Roderick De Greef CFO,
Exec. VP | -- | Guy Sohie Sr. VP, Operations | -- | Jeffery Blanton, 44 VP
- Operations | 130K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|